[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368482-105":59,"doc-detail-368482-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","rare-cancer-survivorship-research-funding-at-the-national-institutes-of-health-nih-2017-to-2023","Rare Cancer Survivorship Research Funding at the National Institutes of Health (NIH), 2017 to 2023","","Rare cancer survivorship needs are less well understood despite advances in detection and treatment. This study characterizes the NIH cancer survivorship grant portfolio focused on rare cancers and identifies scientific gaps. Newly awarded rare-cancer survivorship grants in FY2017–FY2023 were identified, grant characteristics were abstracted, and grant counts for each rare cancer type were mapped to SEER incidence and relative survival. Results show 93 grants, mostly examining four cancers, with limited coverage for others.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/rare-cancer-survivorship-research-funding-at-the-national-institutes-of-health-nih-2017-to-2023/368482/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/rare-cancer-survivorship-research-funding-at-the-national-institutes-of-health-nih-2017-to-2023/368482.png","ImageObject",300,407,{"name":92,"@type":93},"Maya Linwood","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"How were rare-cancer survivorship grants identified for FY2017–FY2023?","Question",{"text":113,"@type":114},"The analysis used NIH cancer survivorship research portfolio data for newly funded grants from FY2017 to FY2023. Grants were identified with text mining using survivorship-relevant terms and then screened using title, abstract, and specific aims.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How many survivorship grants focused on rare cancer types were funded?",{"text":118,"@type":114},"A total of 93 survivorship grants focused on one or multiple rare cancer types were funded from FY2017 to FY2023.",{"name":120,"@type":111,"acceptedAnswer":121},"Which rare cancer types received the most research attention?",{"text":122,"@type":114},"About 85% of grants investigated one of four cancer types: leukemia, head & neck, ovarian, and brain. Several other rare cancers received only a small number of grants.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},368482,1790208959,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":46,"preview_page_count":19,"preview_urls":145},962084928432,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Cancer Causes & Control (2025) 36:587–594 [https://doi.org/10.1007/s10552-025-01959-8](https://doi.org/10.1007/s10552-025-01959-8)  \nRare cancer survivorship research funding at the National Institutes of Health (NIH), 2017 to 2023  \nLisa Gallicchio1,5 · Michelle Mollica2 · GinaTesauro3 · Michelle Doose2 · Jennifer L. Guida3 · Molly E. Maher4 · Emily Tonorezos2  \nReceived: 22 April 2024 / Accepted: 2 January 2025 / Published online: 21 January 2025  \nThis is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2025  \nAbstract  \nPurpose Rare cancers are defined as those for which there are less than 15 cases per 100,000 in the population annually. While much progress in detection and treatment has been made over the past decade for many rare cancers, less progress has been made in understanding survivorship needs. The objective of this study was to characterize the National Institutes of Health (NIH) cancer survivorship grant portfolio focused on rare cancers and to identify gaps specific to this area of science. Methods Newly awarded grants focused on rare cancers in the NIH cancer survivorship research portfolio from Fiscal Year (FY) 2017 to FY2023 were identified. Grant characteristics were abstracted and described. In addition, the number of grants for each rare cancer type was mapped to current Surveillance, Epidemiology, and End Results program incidence and relative survival rates.  \nResults A total of 93 survivorship grants focused on one or multiple rare cancer types were funded from FY2017 to FY2023 . Approximately 85% of these grants investigated one of four cancer types: leukemia, head & neck, ovarian and brain. Few grants focused on other rare cancer types, such as multiple myeloma (n = 5), testicular cancer (n = 3), rectal cancer (n = 1), thyroid cancer (n = 1), and cervical cancer (n = 0). About half of the grants (50.5%) were observational studies; 34.4% focused explicitly on pediatric cancer survivors.  \nConclusions Survivorship research for many rare cancer types is limited. This paucity of research is a barrier to the identification of survivorship needs and the development of interventions to address these needs.  \nKeywords National Institutes of Health · Rare cancers · Research funding · Survivorship  \n* Lisa Gallicchio[lisa.gallicchio@nih.gov](lisa.gallicchio@nih.gov)  \n1 Epidemiology and Genomics Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA  \n2 Office of Cancer Survivorship, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA  \n3 Behavioral Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA  \n4 Healthcare Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA  \n5 National Cancer Institute, 9609 Medical Center Drive, Rockville, MD 20850, USA  \nIntroduction  \nA substantial amount of progress has been made over the last decade in the United States (US) in detecting and treating many rare cancers [1, 2], defined by the National Cancer Institute (NCI) as those for which there are less than 15 cases per 100,000 in the population annually [3] . This progress has resulted in increased survival [4], such that many individuals diagnosed with rare cancers are now living longer, and the goals of their care have changed from cancer cure or palliation at the end of life to addressing survivorship needs. Yet, because of the small number of cases diagnosed relative to the more common cancers, conducting research to understand and address survivorship needs among individuals with rare cancers is challenging. Thus, for many rare cancers, there is a paucity of data on which to guide survivorship care—from diagnosis, through treatment, and to surveillance and management of the possible adverse  \neffects of the cancer diagnosis ","cbCaiehhF5d70zto","https://ap.wps.com/l/cbCaiehhF5d70zto","pdf",646157,"English","# Abstract\n## Purpose\n## Methods\n## Results\n## Conclusions\n# Introduction\n# Methods","[{\"question\":\"How were rare-cancer survivorship grants identified for FY2017–FY2023?\",\"answer\":\"The analysis used NIH cancer survivorship research portfolio data for newly funded grants from FY2017 to FY2023. Grants were identified with text mining using survivorship-relevant terms and then screened using title, abstract, and specific aims.\"},{\"question\":\"How many survivorship grants focused on rare cancer types were funded?\",\"answer\":\"A total of 93 survivorship grants focused on one or multiple rare cancer types were funded from FY2017 to FY2023.\"},{\"question\":\"Which rare cancer types received the most research attention?\",\"answer\":\"About 85% of grants investigated one of four cancer types: leukemia, head \\u0026 neck, ovarian, and brain. Several other rare cancers received only a small number of grants.\"}]","Rare Cancer Survivorship Research Funding at the National Institutes of Health (NIH), 2017 to 2023 | PDF",1790177195,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b17b7dbccdc9853d67fcafa6d40b21e9.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/78513b5facae69980a6315f828c8d72b.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a2c5816166f98849ef7e5edce45c7b6e.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/037ec2201da7637cb59768b53a8a3006.webp",980,1301]